Xu, Jian <br/><br/>
NLG919/cyclodextrin complexation and anti-cancer therapeutic benefit as a potential immunotherapy in combination with paclitaxel.  [electronic resource] 

 -  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences  Oct 2019 
 - 105034 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0720 
<br/><br/><label>Standard No.: </label>10.1016/j.ejps.2019.105034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Calorimetry, Differential Scanning--methods<br/>Cell Line, Tumor<br/>Cyclodextrins--therapeutic use<br/>Female<br/>HeLa Cells<br/>Humans<br/>Imidazoles--therapeutic use<br/>Immunologic Factors--therapeutic use<br/>Immunotherapy--methods<br/>Isoindoles--therapeutic use<br/>Magnetic Resonance Spectroscopy--methods<br/>Mice<br/>Mice, Inbred BALB C<br/>Neoplasms--drug therapy<br/>Paclitaxel--therapeutic use<br/>Small Molecule Libraries--therapeutic use<br/>Solubility--drug effects